Respiratory Analytics
Using sensor tech and data analytics to manage your airways condition
Using sensor tech and data analytics to manage your airways condition
Respiratory Analytics is a UK-based startup pioneering the use of AI, sensor technology, and big data to revolutionize the management of respiratory conditions such as asthma, COPD, and cystic fibrosis. Their flagship product, aflo™, is a 'smart inhaler' designed to assist individuals in correctly administering medication while gathering and analyzing their data alongside air quality and viral information. Supported by funding from Innovate UK, Techstart NI, and CoFund, the company is at the forefront of addressing life-threatening symptoms associated with respiratory ailments. Since its establishment in 2019, Respiratory Analytics operates within the Health Care and Medical Devices sectors, showcasing potential for significant impact and growth.
There is no investment information
No recent news or press coverage available for Respiratory Analytics.
We care about your data, and we'd love to use cookies make your experience better.
